BELGIUM – The European Commission has proposed updated rules on blood, tissue and cells to provide greater protection to donors and recipients and to increase access to innovative transfusion and…
Read MoreTag: Belgium
Salmonella poisoning in 11 countries linked to chocolate products: WHO
SWITZERLAND – The World Health Organization (WHO) has reported more than 150 suspected cases of Salmonellosis, a bacterial intestinal disease that has affected people in Europe and the United States.…
Read MoreUCB completes acquisition of Zogenix for US$1.9bn
BELGIUM – UCB has completed the previously announced acquisition of international biopharmaceutical firm Zogenix for up to US$1.9 billion (€1.7 billion). UCB signed a definitive agreement in January to acquire…
Read MoreMedtronic’s Hugo robotic system performs first surgical procedure in Europe
BELGIUM – Medtronic has announced that the Hugo robotic-assisted surgery (RAS) system was used for the first time in Europe. The robotic prostatectomy was performed by Dr. Alexandre Mottrie, head…
Read MoreUnivercells acquires SynHelix, makes debut into synthetic biology space
BELGIUM – Univercells has entered the synthetic biology space with the acquisition of SynHelix, a French DNA synthesis firm. Univercells, a Belgian bioprocess firm, adds technology aimed at simplifying biotherapeutic…
Read MoreAstraZeneca’s Evusheld scores FDA approval for pre-exposure prevention of COVID-19
UNITED KINGDOM – The Food and Drug Administration (FDA) has approved Evusheld for the pre-exposure prophylaxis of COVID-19 in certain individuals 12 years of age and older weighing at least…
Read MoreNovartis pays US$150 million to gain rights to UCB’s Parkinson’s drug
BELGIUM – Novartis is putting US$150 million into a Parkinson’s disease drug candidate that is competing with drugs in development at companies such as Roche and AstraZeneca. Novartis will pay…
Read MorePDC*line Pharma raises US$20.3 million in Series B2 financing round
BELGIUM – PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, has completed its Series B2 round of funding, raising €17.5…
Read MoreAptar Pharma in exclusive partnership with Stallergenes Greer to develop new medical device
USA – Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, has formed an exclusive partnership with Stallergenes Greer, a global healthcare company specializing…
Read MoreEU launches new authority to prepare for future health crisis
BELGIUM – The European Union has set up a new authority to prevent and rapidly respond to health emergencies based on the lessons learned from the coronavirus crisis. About 30…
Read More